These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17077975)

  • 1. Use of nomograms as predictive tools in bladder cancer.
    Shabsigh A; Bochner BH
    World J Urol; 2006 Nov; 24(5):489-98. PubMed ID: 17077975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
    Kluth LA; Black PC; Bochner BH; Catto J; Lerner SP; Stenzl A; Sylvester R; Vickers AJ; Xylinas E; Shariat SF
    Eur Urol; 2015 Aug; 68(2):238-53. PubMed ID: 25709027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
    Coen JJ; Paly JJ; Niemierko A; Kaufman DS; Heney NM; Spiegel DY; Efstathiou JA; Zietman AL; Shipley WU
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):311-6. PubMed ID: 23474117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms for bladder cancer.
    Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
    Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients.
    Yamada T; Tsuchiya K; Kato S; Kamei S; Taniguchi M; Takeuchi T; Yamamoto N; Ehara H; Deguchi T
    Int J Clin Oncol; 2010 Jun; 15(3):271-9. PubMed ID: 20195678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use and abuse of data: nomograms and talking to patients about clinical medicine.
    Lerner SP; Bochner B; Kibel AS
    Urol Oncol; 2007; 25(4):333-7. PubMed ID: 17628303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
    Zaak D; Burger M; Otto W; Bastian PJ; Denzinger S; Stief CG; Buchner H; Hartmann A; Wieland WF; Shariat SF; Fritsche HM
    BJU Int; 2010 Aug; 106(3):342-8. PubMed ID: 20002664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are nomograms needed in the management of bladder cancer?
    Nguyen CT; Stephenson AJ; Kattan MW
    Urol Oncol; 2010; 28(1):102-7. PubMed ID: 20123358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in bladder cancer.
    Eifler JB; Barocas DA; Resnick MJ
    J Natl Compr Canc Netw; 2014 Nov; 12(11):1549-54. PubMed ID: 25361801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    J Clin Pathol; 2010 Oct; 63(10):910-5. PubMed ID: 20876324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder.
    Moon KC; Kim M; Kwak C; Kim HH; Ku JH
    Ann Surg Oncol; 2014 Sep; 21(9):3132-41. PubMed ID: 24590433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
    Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
    J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting survival after radical cystectomy for bladder cancer.
    Margulis V; Lotan Y; Montorsi F; Shariat SF
    BJU Int; 2008 Jul; 102(1):15-22. PubMed ID: 18325050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.